Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia

References

• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
   PubMed Web of Science ®Google Scholar
• Jelinek DF, Tschumper RC, Stolovitzky GA, et al Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res 2003;1:346–361.
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Alizadeh AA, Widhopf G, et al Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639–1647.
   PubMed Web of Science ®Google Scholar
• Nusse R, Brown A, Papkoff J, et al A new nomenclature for int-1 and related genes: the Wnt gene family. Cell 1991;64:231.
   PubMed Web of Science ®Google Scholar
• Staal FJ, Luis TC, Tiemessen MM. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 2008;8:581–593.
   PubMed Web of Science ®Google Scholar
• Chen X, Yang J, Evans PM, Liu C. Wnt signaling: the good and the bad. Acta Biochim Biophys Sin (Shanghai) 2008;40:577–594.
   PubMed Web of Science ®Google Scholar
• Khan NI, Bendall LJ. Role of WNT signaling in normal and malignant hematopoiesis. Histol Histopathol 2006;21:761–774.
   PubMed Web of Science ®Google Scholar
• Liang H, Chen Q, Coles AH, et al Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003;4:349–360.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001;61:6050–6054.
   PubMed Web of Science ®Google Scholar
• Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol 2006;4:e115.
   PubMed Web of Science ®Google Scholar
• Liang H, Coles AH, Zhu Z, et al Noncanonical Wnt signaling promotes apoptosis in thymocyte development. J Exp Med 2007;204:3077–3084.
   PubMed Web of Science ®Google Scholar
• Ewan KB, Dale TC. The potential for targeting oncogenic WNT/β-catenin signaling in therapy. Curr Drug Targets 2008;9:532–547.
   PubMed Web of Science ®Google Scholar
• Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1–24.
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Cordeu L, Agirre X, et al Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007;109:3462–3469.
   PubMed Web of Science ®Google Scholar
• Khan NI, Bradstock KF, Bendall LJ. Activation of Wnt/β-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol 2007;138:338–348.
   PubMed Web of Science ®Google Scholar
• Lu D, Zhao Y, Tawatao R, et al Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004;101:3118–3123.
   PubMed Web of Science ®Google Scholar
• Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, et al Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer 2008;123:2113–2119.
   PubMed Web of Science ®Google Scholar
• Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, et al Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Iran J Immunol 2008;5:25–35.
   PubMedGoogle Scholar
• Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
   PubMed Web of Science ®Google Scholar
• Farsangi MH, Jeddi-Tehrani M, Sharifian RA, et al Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leuk Lymphoma 2007;48:109–116.
   PubMed Web of Science ®Google Scholar
• Gharagozlou S, Kardar GA, Rabbani H, Shokri F. Molecular analysis of the heavy chain variable region genes of human hybridoma clones specific for coagulation factor VIII. Thromb Haemost 2005;94:1131–1137.
   PubMed Web of Science ®Google Scholar
• Trizio D, Cudkowicz G. Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo. J Immunol 1974;113:1093–1097.
   PubMed Web of Science ®Google Scholar
• Memarian A, Jeddi Tehrani M, Vossough P, Sharifian RA, Rabbani H, Shokri F. Expression profile of Wnt molecules in leukemic cells from Iranian patients with acute myeloblastic leukemia. Iran J Immunol 2007;4:145–154.
   PubMedGoogle Scholar
• Dosen G, Tenstad E, Nygren MK, Stubberud H, Funderud S, Rian E. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. BMC Immunol 2006;29:13–29.
   Web of Science ®Google Scholar
• Chim CS, Pang R, Liang R. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia. J Clin Pathol 2008;61:1214–1219.
   PubMed Web of Science ®Google Scholar
• Wu QL, Zierold C, Ranheim EA. Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia. Blood 2009;113:3031–3039.
   PubMed Web of Science ®Google Scholar
• Omran HA, Shabani M, Vossough P, et al Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission. Leuk Lymphoma 2008;49:281–290.
   PubMed Web of Science ®Google Scholar
• Mikaelsson E, Danesh-Manesh AH, Luppert A, et al Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood 2005;105:4828–4835.
   PubMed Web of Science ®Google Scholar
• Shabani M, Asgarian-Omran H, Jeddi-Tehrani M, et al Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia. Tumour Biol 2007;28:318–326.
   PubMed Web of Science ®Google Scholar
• Kim M, Lee HC, Tsedensodnom O, et al Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 2008;48:780–791.
   PubMed Web of Science ®Google Scholar
• Katoh M. Molecular cloning and characterization of human WNT3. Int J Oncol 2001;19:977–982.
   PubMedGoogle Scholar
• Sukhdeo K, Mani M, Zhang Y, et al Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proc Natl Acad Sci USA 2007;104:7516–7521.
   PubMed Web of Science ®Google Scholar
• Pasca di Magliano M, Biankin AV, Heiser PW, et al Common activation of canonical wnt signaling in pancreatic adenocarcinoma. PLoS ONE 2007;2:e1155.
   PubMedGoogle Scholar
• Bengochea A, de Souza MM, Lefrancois L, et al Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 2008;99:143–150.
   PubMed Web of Science ®Google Scholar
• Kirikoshi H, Sekihara H, Katoh M. Up-regulation of WNT10A by tumor necrosis factor α and Helicobacter pylori in gastric cancer. Int J Oncol 2001;19:533–536.
   PubMed Web of Science ®Google Scholar
• Wang Z, Shu W, Lu MM, Morrisey EE. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol 2005;25:5022–5030.
   PubMedGoogle Scholar
• Person AD, Garriock RJ, Krieg PA, Runyan RB, Klewer SE. Frzb modulates Wnt-9a-mediated β-catenin signaling during avian atrioventricular cardiac cushion development. Dev Biol 2005;278:35–48.
   PubMed Web of Science ®Google Scholar
• Qiang YW, Walsh K, Yao L, et al Wnts induce migration and invasion of myeloma plasma cells. Blood 2005;106:1786–1793.
   PubMed Web of Science ®Google Scholar
• Mazieres J, You L, He B, et al Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 2005;24:5396–5400.
   PubMed Web of Science ®Google Scholar
• Casagrande G, te Kronnie G, Basso G. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. Haematologica 2006;91:765–771.
   PubMed Web of Science ®Google Scholar
• Golan T, Yaniv A, Bafico A, Liu G, Gazit A. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. β-catenin signaling cascade. J Biol Chem 2004;279:14879–14888.
   PubMed Web of Science ®Google Scholar
• Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep 2005;14:1583–1588.
   PubMed Web of Science ®Google Scholar
• Ying J, Li H, Chen YW, Srivastava G, Gao Z, TaoQ. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 2007;110:4130–4132.
   PubMed Web of Science ®Google Scholar
• Sercan HO, Pehlivan M, Simsek O, Ates H, Sercan Z. Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines. Oncol Rep 2007;18:1563–1569.
   PubMed Web of Science ®Google Scholar
• Ghia P, Stamatopoulos K, Belessi C, et al Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005;105:1678–1685.
   PubMed Web of Science ®Google Scholar
• Rassenti LZ, Huynh L, Toy TL, et al ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893–901.
   PubMed Web of Science ®Google Scholar
• Bomben R, Dal Bo M, Capello D, et al Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood 2007;109:2989–2998.
   PubMed Web of Science ®Google Scholar